Oral administration of muramyl dipeptide into mice modulates cell proliferation, immunoglobulin synthesis and cytokine mRNA levels in gut associated lymphoid tissues

This publication has 8 references indexed in Scilit:

• Induction in mice of serum IgE levels after treatment with anti-mouse IgD antibodies is preceded by differential modulation of tissue cytokine gene transcription
  European Journal of Immunology, 1995
• Control of IgE responses: II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutide
  Immunopharmacology, 1993
• Photoaffinity labelling of macrophages and B-lymphocytes using 125I-labelled aryl-azide derivatives of muramyldipeptide
  International Journal of Immunopharmacology, 1989
• The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.
  The Journal of Experimental Medicine, 1988
• Binding sites for peptidoglycan on mouse lymphocytes
  Cellular Immunology, 1987
• Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release
  Biochemical and Biophysical Research Communications, 1985
• Biologic properties of a new synthetic adjuvant, muramyl dipeptide (MDP)
  Springer Seminars in Immunopathology, 1979
• Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
  Biochemical and Biophysical Research Communications, 1974